News

Feliza Mirasol is the science editor for 

Articles

Biotech firm Lumen Bioscience has received fast track designation from FDA for its oral biologic drug candidate for treating C. difficile infection.

FDA Grants Lumen Bioscience Fast Track Designation for Oral Biologic

Gilead Sciences and Arcus Biosciences have expanded their research collaboration to include inflammatory diseases in addition to oncology. 

Gilead Sciences and Arcus Biosciences Expand Research Partnership

Grant Playter is the Assistant Editor for 

Astellas and Sony will collaborate to discover a novel ADC platform for use in oncology.

Astellas and Sony Enter ADC Platform Collaboration

Avirmax’s new gene therapy facility in Hayward, Calif., will specialize in AAV gene therapy research and development.

Avirmax Opens New Gene Therapy Facility

Under the collaboration, BiOneCure Therapeutics and Nanjing Leads Biolabs intend to develop a range of innovative antibody-drug conjugates for treating solid tumors.

BiOneCure Therapeutics and Nanjing Leads Biolabs Partner to Develop ADCs for Solid Tumors

In a deal potentially worth more than $530 million, Amgen will use TScan Therapeutics’ target discovery platform to home in on novel targets for Crohn’s disease treatment.

Amgen and Tscan Therapeutics Team Up to Identify Novel Targets in Crohn's Disease

The new partnership between Sandoz, a Novartis division, and Just – Evotec Biologics will aim to develop and manufacture multiple biosimilars.

Sandoz and Just – Evotec Biologics Form Biosimilars Pact

Private investors from Advent International and Warburg Pincus will operate the assets as an independent CDMO.

Baxter Divests BioPharma Solutions Department in $4.25 Billion Deal

FDA’s Division of Applied Regulatory Science’s (DARS) computational toxicology and pharmacology research has been focused on the development of highly curated data sets and QSAR models for endpoints of regulatory interest.

New QSAR Model for Predicting Blood Brain Barrier Permeability

New therapeutic opportunities are offering significant promise for the bio/pharma industry and patients.

Biopharma News